Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis associated with the human immunodeficiency virus].

M Gérard1

  • 1Clinique des Maladies infectieuses, C.H.U. Saint Pierre, U.L.B.

Revue Medicale De Bruxelles
|June 1, 2000
PubMed
Summary

The HIV pandemic fuels tuberculosis (TB) cases globally, particularly in Africa. Co-infection worsens outcomes for both diseases, necessitating tailored treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profile of pregnant women complying or not with physical activity recommendations during the second trimester of pregnancy: A French pilot study.

Journal of gynecology obstetrics and human reproduction·2025
Same author

Haze factor of silver nanowires in variable refractive index environment: experimental and simulation approaches.

Nanotechnology·2024
Same author

[An update in intrauterine contraception].

Revue medicale de Liege·2022
Same author

Secondary structure prediction of long noncoding RNA: review and experimental comparison of existing approaches.

Briefings in bioinformatics·2022
Same author

Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy.

Scandinavian journal of rheumatology·2022
Same author

Staggered enforcement of infection control and prevention measures following four consecutive potential laboratory exposures to imported <i>Brucella melitensis</i>.

Infection prevention in practice·2021

Area of Science:

  • Infectious Diseases
  • Public Health
  • Immunology

Context:

  • The human immunodeficiency virus (HIV) pandemic significantly contributes to the global rise in tuberculosis (TB) cases, especially in sub-Saharan Africa.
  • The interplay between Mycobacterium tuberculosis (M. tuberculosis) and HIV (M. tuberculosis/HIV co-infection) leads to increased susceptibility to TB reactivation or progression in HIV-infected individuals.
  • Tuberculosis negatively impacts the natural history of HIV, increasing clinical progression and mortality rates.

Purpose:

  • To highlight the copathogenicity of M. tuberculosis and HIV.
  • To describe the clinical presentation and treatment of TB in HIV-infected individuals.
  • To outline management strategies, including prophylaxis and therapy duration, for M. tuberculosis/HIV co-infection.

Summary:

  • HIV-infected individuals exhibit high susceptibility to TB, with atypical and severe presentations in advanced immunosuppression (e.g., no cavitation, visceral involvement, positive blood cultures).
  • Standard 6-month anti-TB therapy is effective, but 9 months are recommended for severe cases with advanced immunosuppression.
  • Challenges include a higher frequency of anti-TB drug side effects, drug interactions (rifamycin and antiretrovirals via CYP3A), and paradoxical reactions post-immuno-restoration.

Impact:

  • Isoniazid prophylaxis in PPD-positive individuals reduces TB development risk by 60%.
  • Effective management of M. tuberculosis/HIV co-infection is crucial for improving patient outcomes and controlling the dual epidemics.
  • Understanding drug interactions and managing immune reconstitution inflammatory syndrome (IRIS) are vital for successful treatment in co-infected patients.

Related Experiment Videos